Home > Boards > US Listed > Medical - Drugs >

Merck & Co. Inc. (MRK)

MRK RSS Feed
Add MRK Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/13/2021 12:07:28 PM - Followers: 52 - Board type: Free - Posts Today: 0
MRK
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MRK News: Merck's Keytruda meets dual primary endpoint in late-stage triple-negative breast cancer study 05/13/2021 08:29:41 AM
MRK News: Merck Announces Phase 3 KEYNOTE-522 Trial Met Dual Primary Endpoint of Event-Free Survival (EFS) in Patients With High-Risk E... 05/13/2021 06:45:00 AM
MRK News: Viatris earns mixed views from analysts despite more clarity in Q1 results 05/12/2021 03:41:15 PM
MRK News: Statement of Changes in Beneficial Ownership (4) 05/11/2021 02:41:37 PM
MRK News: Dosing underway in ALX Oncology's ALX148 combo study in head and neck cancer 05/10/2021 09:53:56 AM
PostSubject
#597   Keytruda hits EFS co-primary_endpoint_in_neoadjuvant/adjuvant TNBC: DewDiligence 05/13/21 12:07:28 PM
#596   This news from NIH and Salk Institute may north40000 05/03/21 06:05:30 PM
#595   Organon Investor Day slides: DewDiligence 05/03/21 01:33:43 PM
#594   Organon-spinoff Investor Day PR: DewDiligence 05/03/21 11:12:20 AM
#593   2021 non-GAAP EPS guidance unchanged at $6.48-6.68, +12-15% YoY. DewDiligence 04/29/21 08:21:03 AM
#592   MRK 1Q21 items… DewDiligence 04/29/21 08:04:32 AM
#591   MRK—Keytruda sBLA in TNBC—>CRL: DewDiligence 03/29/21 04:35:34 PM
#590   OT: I have been using Vascepa with generic north40000 03/27/21 04:41:10 AM
#589   FDA approves Keytruda/chemo in first-line esophageal cancer irrespective DewDiligence 03/23/21 10:18:05 AM
#588   Thanks for the reply, I would encourage always stocktrademan 03/16/21 03:27:49 AM
#587   Yes. While I don’t advise not Bigspirit1 03/15/21 01:43:17 PM
#586   It is time to buy MRK as a stocktrademan 03/02/21 01:16:28 PM
#585   there are rumors of a new contract for F1Greenwest 02/18/21 08:45:26 AM
#584   MRK—FDA briefing docs disparage KEYNOTE-522 study in adjuvant-TNBC: DewDiligence 02/05/21 12:56:10 PM
#583   CEO, Ken Frazier retiring effective 6/30/21: DewDiligence 02/04/21 07:40:34 AM
#582   MRK 4Q20 items… DewDiligence 02/04/21 07:38:28 AM
#581   Merck has always been good for me 2020trader 02/03/21 08:06:55 PM
#580   Merck is a safe place to "Bank Money", FUNMAN 02/03/21 04:03:24 PM
#579   nice dividend 2020trader 02/03/21 03:59:26 PM
#578   Keytruda/Yervoy_bombs_in_1L-NSCLC—numerically_worse_than_Keytruda_monotherapy: DewDiligence 01/30/21 11:52:00 AM
#577   Merck could easily buy WPD Pharma, who develop coffee2go 01/08/21 10:29:17 AM
#576   $MRK pipeline continues to expand. Target in 8-10 Seeker213 12/16/20 07:40:35 AM
#575   MRK submits BLA/MAA for V114 pneumococcal vaccine in adults: DewDiligence 11/23/20 08:38:53 AM
#574   MRK acquires—(private)—Oncoimmune for $425M cash plus contingent payments: DewDiligence 11/23/20 08:34:35 AM
#573   Merck Announces First-Quarter 2021 Dividend FUNMAN 11/17/20 01:56:39 PM
#572   FDA_approves_Keytruda/chemo_ in_1L-metastatic_or locally_recurrent_TNBC_with_PD- DewDiligence 11/13/20 05:43:34 PM
#571   Keytruda+Yervoy_not_better_than_Keytruda_monotherapy_in_1L-NSCLC with PD-L1>=50% DewDiligence 11/09/20 06:46:58 PM
#570   MRK acquires—(private)—VelosBio_for_$2.75B cash: DewDiligence 11/05/20 08:24:41 AM
#569   PFE shareholders who swapped their shares for ZTS DewDiligence 11/03/20 10:34:56 AM
#568   PFE spun $ZTS and the rest is history Seeker213 11/03/20 10:31:54 AM
#567   Animal-health is MRK’s fastest growing division, which is DewDiligence 11/03/20 09:30:30 AM
#566   Spin off the pet meds and reward your Seeker213 11/03/20 05:52:34 AM
#565   MRK 3Q20 results—non-GAAP EPS guidance raised… DewDiligence 10/27/20 11:38:48 AM
#564   V114—MRK’s 15-valent pneumococcal vaccine—meets primary endpoint in two DewDiligence 10/20/20 10:53:52 AM
#563   FDA approves Keytruda monotherapy for rrcHL, based on DewDiligence 10/15/20 11:54:50 AM
#562   MRK’s Roger Perlmutter retires effective at year-end: DewDiligence 10/02/20 11:10:27 AM
#561   MRK’s ESMO slides: DewDiligence 09/22/20 11:15:42 AM
#559   MRK’s ESMO data for early-stage pipeline—Vibostolimab/MK-7684 (anti-TIGIT); MK-4830 DewDiligence 09/20/20 01:47:05 PM
#558   Keytruda monotherapy in adjuvant-melanoma—>statsig DMFS* benefit @3.5 years: DewDiligence 09/19/20 12:15:32 PM
#557   MRK, SGEN ink global development/commercialization deal for Ladiratuzumab Vedoti DewDiligence 09/14/20 09:37:21 AM
#556   V114—MRK’s 15-valent pneumococcal vaccine—meets primary endpoint in phase-3 DewDiligence 09/09/20 10:49:05 AM
#555   Merck & Co. Inc should buyout MYMX (Mymetics) bow-tie 09/03/20 12:04:42 AM
#554   Article mentioning Merck & Co. Nfixus 08/31/20 03:55:59 PM
#553   Keytruda/chemo shows statsig-superior OS vs chemo alone in DewDiligence 08/19/20 10:55:40 AM
#552   Barron’s like MRK—for both valuation and COVID-19 opportunity: DewDiligence 08/15/20 03:34:29 PM
#550   MRK enters the NASH arena: DewDiligence 08/04/20 11:34:54 AM
#549   News: $MRK Merck & Co. (MRK) Q2 2020 whytestocks 08/01/20 08:45:34 AM
#548   MRK 2Q20 items… DewDiligence 07/31/20 09:10:29 AM
#547   Vericiguat/heart-failure PDUFA—>1/20/21 (with FDA priority review): DewDiligence 07/16/20 10:14:44 AM
#546   Keytruda monotherapy BLA in rrcHL—>10/30/20 PDUFA (with FDA DewDiligence 07/09/20 09:49:13 AM
PostSubject
Consent Preferences